Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutogliptin Extension Study in T2DM
NCT01089790Phase 3Terminated
- Sponsor
- Forest Laboratories
- Start
- Mar 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dutogliptin in type 2 diabetes mellitus (T2DM), sponsored by Forest Laboratories. Started Mar 2010; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01089790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089790.